Fed. Circ. Mulls Reviving Fight Over Opioid Blocker Patent
At least one Federal Circuit judge seemed wary Tuesday of the logic a lower court used to reject a suit from Mylan Pharmaceuticals that claimed a rival's patent for an opioid...To view the full article, register now.
Already a subscriber? Click here to view full article